Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.
about
The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a reviewSulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase GEnhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancerEnhancement of antitumor activity of docetaxel by celecoxib in lung tumors.Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction.Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancerPhosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activityRoles of sildenafil in enhancing drug sensitivity in cancer.Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells.PDE5 inhibitors as therapeutics for heart disease, diabetes and cancerSuppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10.Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivoThe cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinomaPhosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatmentA novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activitySildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagyPhase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants.Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell linesSulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model.Pharmacological modulation of cytotoxicity and cellular uptake of anti-cancer drugs by PDE5 inhibitors in lung cancer cellsSildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.Dynamic CT imaging of volumetric changes in pulmonary nodules correlates with physical measurements of stiffness.The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatmentCOX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach.Synthesis of novel tadalafil analogues and their evaluation as phosphodiesterase inhibitors and anticancer agents.Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition.Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling.PDE5 Overexpression in Well-Differentiated Thyroid Carcinomas Is Associated with Lymph Node Metastasis.Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer.Phosphodiesterase type 5 and cancers: progress and challenges.
P2860
Q26785428-02F8DAA0-E99B-4C20-A9C6-B648B306940AQ33585342-221EA108-962E-4BEC-B377-A9BEC65F3621Q33837550-87D6B516-40AA-4A9C-99D9-9150C93DE0F8Q34008146-77F273AA-5ED5-4D41-B47A-0E6C4819BBD5Q34241307-B635788C-5E5D-408E-B71B-EA8108E0BB9AQ34300257-E2306C5C-9FC5-4FBF-9955-AF655D083CA1Q34416260-F372719D-E1C6-4507-9129-30AE61A36614Q35022148-DFA248E4-3DB8-4E89-B921-7FFB1B19AE1BQ35151018-DFA85BC7-D7E9-4DF6-B9B4-E8C0BF280C84Q35827798-B178D628-918B-494A-80C8-33E7A0ED8D15Q36413785-40D2472C-FE96-42D5-B7F4-D98CD376F16CQ36420145-6FEA8B3F-1683-40A8-B8CE-2A933990F5C7Q36458158-3A293F9F-0C2B-43E7-AA71-57BC34B63056Q36503940-79231C03-309B-41A8-A5F5-3E6E40242B56Q36537864-DE5BAD4B-F71D-4C10-9FBA-A6D3600769A0Q36782452-2B195F9C-CF6F-46AC-A751-D6029AA91FD6Q36836915-B6567B34-6777-43AD-ACD5-1D052B92EF80Q36924607-6C776D2E-D31B-41DE-823B-E9A7B32F3518Q36952021-F666C557-5740-41EC-BEAB-FD8236007596Q37103526-2139D97B-D69E-4CC3-818D-55FB84D57EB6Q37238527-B6B87C12-9B68-4C40-ADED-1867DC38D1FBQ37338514-006909A6-F3ED-43B7-813D-3322AE56E365Q37395863-2DD79DEF-604B-44FB-A0BD-D1C7FB165037Q37426831-A87B7541-E351-4BBC-A3EF-DDE515C55BB5Q37656819-03FDB987-C627-43A5-A5D0-A91D31D87326Q37693485-B9343C4C-0F03-46CC-B23C-9447D95DEF8CQ38123175-09BFF866-0692-4049-B58A-9F73394BA801Q39202347-ED52943B-7966-4FA6-8D84-CA2232E21440Q39786514-709DC09C-1545-4299-BEB5-61040D84DE62Q39790023-E5A7AA0F-3308-4191-B7ED-45B9B3855C4FQ42135630-F7BFFB49-5293-4E83-843D-48CEF63D560BQ42378330-F6F370E4-B4FE-47D1-9B9E-F0396598D29EQ43268349-972DF464-4BB3-407D-B2E1-09BBBA49706BQ47138288-D0B70781-F9D8-41E2-A966-5510D54FAF96Q47171803-407F1C69-64EC-4160-9408-6F4800AC4168
P2860
Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Exisulind-induced apoptosis in ...... ributes to increased survival.
@ast
Exisulind-induced apoptosis in ...... ributes to increased survival.
@en
type
label
Exisulind-induced apoptosis in ...... ributes to increased survival.
@ast
Exisulind-induced apoptosis in ...... ributes to increased survival.
@en
prefLabel
Exisulind-induced apoptosis in ...... ributes to increased survival.
@ast
Exisulind-induced apoptosis in ...... ributes to increased survival.
@en
P2093
P1476
Exisulind-induced apoptosis in ...... ributes to increased survival.
@en
P2093
Andres J P Klein-Szanto
Clark M Whitehead
Daniel C Chan
Gary Piazza
Hector Alila
John Fetter
Keith A Earle
Paul A Bunn
Rifat Pamukcu
Songmei Xu
P304
P577
2003-05-01T00:00:00Z